Clinical Trial Liability Insurance for Biotech Startups in Delaware and Pennsylvania

Why the insurance question arrives sooner than founders expect

For many life sciences founders in Wilmington, Philadelphia, Princeton, Baltimore and Richmond, the first serious insurance conversation does not start with an agent. It starts when a hospital or university research site sends over its clinical trial agreement and a contracts officer asks for proof of coverage. At that point the study timeline is already set, the investigators are lined up, and an insurance gap can hold up first patient in.

Our goal with this guide is to help you see that request coming, understand where it comes from, and prepare a clean submission well before the agreement is ready to sign.

What federal rules say, and what they do not say

Federal human subject protection rules focus on what participants are told, not on how much insurance a sponsor buys.

Under 21 CFR 50.25(a)(6), the informed consent for research involving more than minimal risk must explain whether any compensation and whether any medical treatments are available if injury occurs, and where to get more information. Under 21 CFR 50.20, no informed consent may include exculpatory language through which a participant waives, or appears to waive, legal rights, or that releases or appears to release the investigator, the sponsor, the institution or its agents from liability for negligence.

Part 50 does not set an insurance requirement or a dollar amount. In practice, the requirement comes from the contract. That is why the clinical trial agreement, not a federal form, usually drives what you need to buy.

What research sites commonly ask sponsors to carry

The Accelerated Clinical Trial Agreement (ACTA) is a standardized template for industry-sponsored, multi-site clinical trials. It was developed by the CTSA Master Contracts Working Group, which brought together legal experts from about 25 academic research institutions, working with industry sponsors and the University-Industry Demonstration Partnership, to reduce contract negotiation delays.

The ACTA template (version dated October 15, 2014) gives a useful picture of a typical ask. Its insurance section calls for the sponsor to procure and maintain commercial general liability insurance, clinical trial insurance and products liability insurance, or equivalent self-insurance, in amounts not less than $3,000,000 per occurrence and $10,000,000 annual aggregate unless a work order says otherwise, including contractual liability coverage for the sponsor's indemnification obligations. Its subject injury section asks the sponsor to reimburse the reasonable and necessary costs of diagnosis and treatment of a participant injury caused by the study drug or device or a required protocol procedure, with carve-outs for the institution's own negligence or willful misconduct and for the natural progression of a pre-existing condition.

Every site negotiates its own paper, and your agreement may differ. The takeaway is that three things usually travel together: an indemnification promise, a subject injury promise, and an insurance requirement meant to stand behind both. Your coverage should be reviewed against all three, not just the limit.

Indemnification, certificates and the paperwork trail

Three documents need to tell the same story: the clinical trial agreement, the informed consent, and the insurance policy. If the agreement promises to pay for treatment of research injuries, the consent form describes what participants will receive, and the policy is silent or excludes the situation, the sponsor may be left to fund that promise from its own balance sheet.

A few practical habits help keep those documents aligned:

•Read the indemnification clause with the insurance clause. The ACTA template ties them together by asking for contractual liability coverage for the sponsor's indemnification obligations. Ask whether your policy responds to liability you have assumed by contract.

•Track every party that wants proof of coverage. Sites, contract research organizations and some investors may each ask for a certificate of insurance, and some will ask for specific wording.

•Keep the certificate consistent with the policy. A certificate is evidence of coverage, not a promise of broader coverage. If a request goes beyond what the policy provides, the answer is to change the policy or negotiate the request, not to stretch the certificate.

What clinical trial liability insurance is designed to do

A clinical trial liability policy is built to respond when a participant alleges bodily injury connected to the study, including the cost of defending that claim. Policy wording varies widely from market to market, so the details matter more than the label.

Many liability policies in this space are written on a claims-made basis. The National Association of Insurance Commissioners explains that under a claims-made form, the policy in effect when a claim is reported responds, with coverage continuing during any applicable extended reporting period. An occurrence form, by contrast, covers a loss that occurs during the policy period regardless of when the claim is made.

For a sponsor, that distinction is practical. A participant may not report a problem until well after the last visit. Before the study closes, you want a plan for keeping coverage in force or securing an extended reporting period so that a late claim still has a policy to respond.

The rest of a startup sponsor's insurance picture

Clinical trial coverage is one piece. We encourage founders and boards to review the full program at the same time.

•Products liability. If the product moves toward commercial sale, products liability becomes the core exposure.

•General liability and property. Labs, office space, equipment and temperature-sensitive materials each raise their own questions, and landlords often have their own insurance requirements in the lease.

•Workers' compensation. Each of our five states sets its own rules. In Virginia, for example, employers that regularly employ more than two part-time or full-time employees must carry coverage.

•Directors and officers liability. Investors and independent directors frequently ask about D&O before they join a board.

•Cyber liability. Trial data, vendor systems and email are all exposures worth a conversation.

•Employment practices liability. Fast hiring brings its own risks.

Five things to gather before you request quotes

Study basics. Phase, number of participants, number of sites and the start and end dates.
The product. Whether it is a drug, a biologic or a device, and a plain-language summary of how it is administered.
Every insurance clause you have received. Site agreements, CRO agreements and any investor or landlord requirements.
Your informed consent language on injury. It should line up with what you have promised in your contracts.
Your plan after the last visit. How long you intend to keep coverage in force, and whether an extended reporting period may be needed.

Bringing these to the first meeting shortens the process and helps us present your study clearly to underwriters.

Sites outside our footprint

Prominent Insurance Services is licensed for personal and commercial lines in Delaware, Pennsylvania, New Jersey, Maryland and Virginia. If your study includes sites outside those states, we will tell you so plainly and coordinate with an appropriately licensed partner or make a referral, rather than work around licensing rules.

How Prominent helps life sciences sponsors

We are an independent agency headquartered in Wilmington, Delaware. For an emerging sponsor, our work typically includes reading the insurance and indemnification clauses in your agreements alongside your counsel, mapping each requirement to a line of coverage, approaching the appointed carriers and specialty markets that write this class of business, and coordinating certificates of insurance so a site's contracts office has what it needs. We cannot promise a price or that any particular market will offer terms, but we can make sure your submission is complete and that you understand what you are buying.

If you are preparing a first study, the best time to talk is before the clinical trial agreement is final.

Frequently asked questions

Is clinical trial insurance required by federal law in the United States?

Federal human subject rules do not set an insurance requirement or a dollar amount. Under 21 CFR 50.25(a)(6), the informed consent for research involving more than minimal risk must explain whether compensation and medical treatment are available if injury occurs. The insurance requirement usually comes from the clinical trial agreement with the research site.

How much clinical trial liability coverage do research sites ask for?

It varies by site and study. As one example, the Accelerated Clinical Trial Agreement template calls for general liability, clinical trial and products liability insurance with minimums of $3,000,000 per occurrence and $10,000,000 annual aggregate unless a work order says otherwise. Always read the insurance clause in your own agreement.

Will my general liability policy cover injuries to trial participants?

Do not assume it will. Policy wording varies, and research sites typically ask for clinical trial coverage specifically. Ask your agent to review your current policies against the agreement and confirm in writing how participant injury claims would be handled.

What does claims-made mean, and why does it matter after the study ends?

The NAIC explains that under a claims-made policy, the policy in effect when a claim is reported responds, including during any applicable extended reporting period. Because participants may report problems after the last visit, sponsors should plan how coverage will stay in force or whether an extended reporting period is needed.

Can Prominent help if some of our study sites are outside DE, PA, NJ, MD and VA?

Prominent Insurance Services is licensed in Delaware, Pennsylvania, New Jersey, Maryland and Virginia. For sites outside those states, we will say so plainly and coordinate with an appropriately licensed partner or make a referral.

Disclaimer: This article is general education, not legal advice. Insurance requirements depend on your contracts, your operations and the policy language. Coverage is subject to underwriting and the terms of each policy. Consult your attorney about contract terms and your licensed agent about coverage.

Book a 30-minute review or call 302-351-3368. Prominent Insurance Services is an independent insurance agency headquartered at 1201 N Orange St Suite 7295, Wilmington, DE 19801, licensed for personal and commercial lines in Delaware, Pennsylvania, New Jersey, Maryland and Virginia.

Reviewed by Jason Rodriguez, CIC, CPRM, Principal Advisor.